Showing results (31-40 of 443) with videos related to
Sort By:
Pageof 45
The Oncologist|October 20, 2019
Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell LeukemiaRobert J Kreitman, Ira PastanCurrent Opinion in Investigational Drugs (London, England : 2000)|August 21, 2002
Immunotoxins in cancer therapyIra Pastan, Robert J KreitmanBest Practice & Research. Clinical Haematology|September 26, 2006
BL22 and lymphoid malignanciesRobert J Kreitman, Ira PastanBiomolecules|November 27, 2021
Immunotoxins: From Design to Clinical ApplicationRobert J Kreitman, Ira PastanHematology/Oncology Clinics of North America|September 23, 2006
Immunotoxins in the treatment of refractory hairy cell leukemiaRobert J Kreitman, Ira PastanClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2011
Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotoxRobert J Kreitman, Ira PastanBiomolecules|August 7, 2020
Development of Recombinant Immunotoxins for Hairy Cell LeukemiaRobert J Kreitman, Ira PastanProceedings of the National Academy of Sciences of the United States of America|March 28, 2018
Recombinant immunotoxins with albumin-binding domains have long half-lives and high antitumor activityJunxia Wei, Tapan K Bera, Xiu Fen Liu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISAMasanori Onda, Mark Willingham, Satoshi Nagata, et al.Proceedings of the National Academy of Sciences of the United States of America|February 15, 2019
Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunityMasanori Onda, Kazuto Kobayashi, Ira PastanPageof 45